A股異動 | 華大九天漲5% 部分數字工具支持5nm 並已實現商業化
格隆匯2月14日丨華大九天漲5.24%,報104.8元,總市值569億元。消息面上,公司宣佈部分數字工具支持5nm,是指此部分工具已經實現商業化。在模擬和全定製領域,公司正在推進支持先進工藝的模擬設計全流程系統,並在模擬全流程的基礎上,開發面向全定製領域的全流程工具,包括存儲全流程、射頻全流程、光電全流程、先進封裝設計等;在數字領域,公司正在研發數字領域相關核心工具,逐步補齊數字核心工具短板,不斷完善公司在數字領域的佈局;在晶圓製造領域,公司針對快速增長的市場需求,正在研發晶圓製造相關核心工具,不斷增強公司對晶圓製造廠的支撐能力。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.